Literature DB >> 8275491

Allelotype of human bladder cancer.

M A Knowles1, P A Elder, M Williamson, J P Cairns, M E Shaw, M G Law.   

Abstract

To identify common regions of deletion in human bladder tumors, we have screened 83 cases of transitional cell carcinoma for loss of heterozygosity (LOH) on all autosomal chromosome arms. Seventy-two restriction fragment length polymorphism, variable number of tandem repeats, and minisatellite markers and 18 microsatellite markers were used to obtain a minimum of 50% informative results for each chromosome arm. A mean of 29.6 informative results per patient was obtained from 39 chromosome arms studied, representing information for 76% of chromosome arms. The most frequent losses were apparent monosomies of chromosome 9 (9p, 51%; 9q, 57%). Other frequent losses were on chromosomes 11p (32%), 17p (32%), 8p (23%), 4p (22%), and 13q (15%). LOH of 4p has not been reported previously in bladder carcinoma. The frequency of LOH on all other chromosome arms was < 12%. LOH on chromosome 8p showed a significant association with both high tumor grade and stage, and LOH on 13q showed a significant association with high tumor grade. Fractional allelic loss was calculated for all tumors and had a mean of 0.125 and a median of 0.110. A significant association was found between increased fractional allelic loss and higher tumor grade. An association was also found between LOH of chromosomes 8p and 9q and values for fractional allelic loss > or = the median value. No associations were found between LOH on different pairs of chromosome arms.

Entities:  

Mesh:

Year:  1994        PMID: 8275491

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  Impact of holmium:YAG and neodymium:YAG lasers on the efficacy of DNA delivery in transitional cell carcinoma.

Authors:  Thomas Knoll; Lutz Trojan; Sigrun Langbein; Sreedhar Sagi; Peter Alken; Maurice Stephan Michel
Journal:  Lasers Med Sci       Date:  2004-06-23       Impact factor: 3.161

Review 2.  Biomolecular predictors of urothelial cancer behavior and treatment outcomes.

Authors:  Michael Rink; Eugene K Cha; David Green; Jens Hansen; Brian D Robinson; Yair Lotan; Arthur I Sagalowsky; Felix K Chun; Pierre I Karakiewicz; Margit Fisch; Douglas S Scherr; Shahrokh F Shariat
Journal:  Curr Urol Rep       Date:  2012-04       Impact factor: 3.092

3.  Cloning and characterization of the porcine DBC1 gene encoding deleted in bladder cancer.

Authors:  Knud Larsen; Jamal Momeni; Leila Farajzadeh; Christian Bendixen
Journal:  Mol Biol Rep       Date:  2014-09-26       Impact factor: 2.316

Review 4.  Genetics of bladder cancer.

Authors:  K K Saran; D Gould; C J Godec; R S Verma
Journal:  J Mol Med (Berl)       Date:  1996-08       Impact factor: 4.599

5.  The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.

Authors:  M J Seraj; M A Harding; J J Gildea; D R Welch; D Theodorescu
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

6.  Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma.

Authors:  Markus Riester; Lillian Werner; Joaquim Bellmunt; Shamini Selvarajah; Elizabeth A Guancial; Barbara A Weir; Edward C Stack; Rachel S Park; Robert O'Brien; Fabio A B Schutz; Toni K Choueiri; Sabina Signoretti; Josep Lloreta; Luigi Marchionni; Enrique Gallardo; Federico Rojo; Denise I Garcia; Yvonne Chekaluk; David J Kwiatkowski; Bernard H Bochner; William C Hahn; Azra H Ligon; Justine A Barletta; Massimo Loda; David M Berman; Philip W Kantoff; Franziska Michor; Jonathan E Rosenberg
Journal:  Clin Cancer Res       Date:  2014-01-31       Impact factor: 12.531

7.  Critical evaluation of urinary markers for bladder cancer detection and monitoring.

Authors:  Shahrokh F Shariat; Jose A Karam; Yair Lotan; Pierre I Karakiewizc
Journal:  Rev Urol       Date:  2008

8.  Uroplakin gene expression by normal and neoplastic human urothelium.

Authors:  E D Lobban; B A Smith; G D Hall; P Harnden; P Roberts; P J Selby; L K Trejdosiewicz; J Southgate
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

9.  Mutations and altered expression of p16INK4 in human cancer.

Authors:  A Okamoto; D J Demetrick; E A Spillare; K Hagiwara; S P Hussain; W P Bennett; K Forrester; B Gerwin; M Serrano; D H Beach
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder.

Authors:  M Li; Z F Zhang; V E Reuter; C Cordon-Cardo
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.